MRA Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MRA Advisory Group's LLY Position: Q3 2026 in Review
MRA Advisory Group increased its Eli Lilly (LLY) stake by 194% in Q3 2026, buying an estimated $669K and bringing the position to 859 shares worth $994K. The position accounts for 0.37% of the portfolio, ranked #45.
MRA Advisory Group first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.19M in Q2 2024. 1,879 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- MRA Advisory Group held 859 shares of Eli Lilly worth $994K as of Q3 2026.
- MRA Advisory Group bought 567 Eli Lilly shares in Q3 2026, an estimated $669K.
- Eli Lilly made up 0.37% of MRA Advisory Group's portfolio in Q3 2026, its #45 holding.
- MRA Advisory Group first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- MRA Advisory Group's Eli Lilly position peaked at $1.19M in Q2 2024.
- 1,879 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.